65 Results for "

COMT

" in MedChemExpress (MCE) Product Catalog:
Products (65)

65 Results for "COMT" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-P72149
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: COMT; Catechol-O-Methyltransferase Isoform; Catechol-O-Methyltransferase; Testicular Tissue Protein Li 42; Catechol O-Methyltransferase; HEL-S-98n; Epididymis Secretory Sperm Binding Protein Li 98n
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P74230
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: COMT; Catechol-O-Methyltransferase Isoform; Catechol-O-Methyltransferase; Testicular Tissue Protein Li 42; Catechol O-Methyltransferase; HEL-S-98n; Epididymis Secretory Sperm Binding Protein Li 98n
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P82269
Synonyms: Catechol O methyltransferase; COMT

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-B1473AR
CAS No.: 50-67-9
Synonyms: 5-Hydroxytryptamine (Standard); 5-HT (Standard)
Serotonin (Standard) is the analytical standard of Serotonin (HY-B1473A). This product is intended for research and analytical applications. Serotonin is a monoamine neurotransmitter in the CNS and an endogenous 5-HT receptor agonist. Serotonin is also a catechol O-methyltransferase (COMT) inhibitor with a Ki of 44 μM.
loading...
    loading...
Cat. No.: HY-L086
3,759 compounds

Neurodegenerative diseases are incurable and life-threatening conditions that result in progressive degeneration and/or death of nerve cells. Some common neurodegenerative diseases include Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Motor Neuron Disease (MND), Huntington’s Disease (HD), Spino-Cerebellar Ataxia (SCA), Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS). Because the pathophysiology of neurodegenerative disorders is generally poorly understood, it is difficult to identify promising molecular targets and validate them. At the same time, about 85% of the drugs fail in clinical trials. Therefore, validating new targets and discovering new drugs to mitigate neurodegenerative disorders is need of the hour.

MCE offers a unique collection of 3,759 compounds with anti-Neurodegenerative Diseases activities or targeting the unique targets of neurodegenerative diseases. MCE Neurodegenerative Disease-related Compound Library is a useful tool for exploring the mechanism of neurodegenerative diseases and discovering new drugs for neurodegenerative diseases.